Gram-positive cocci are often isolated from clinical samples. It is important to be able to distinguish these organisms from one another because while some are normal flora, others can be pathogenic.

Preclinical studies have demonstrated the compound’s activity against Gram-negative bacteria. “We are excited to enter the clinical development phase with the ABX-01 lead candidate ...